CVEvulnerability
CVE-2018-14786
9.4 CRITICAL
Official page ↗
- Status
- Modified
- Published
- 2018-08-23
- Last modified
- 2026-06-17
- Assigner
- [email protected]
- CVSS 3.0 ([email protected])
- 9.4 CRITICAL — CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
- CVSS 2.0 ([email protected])
- 7.5 HIGH — AV:N/AC:L/Au:N/C:P/I:P/A:P
- Weaknesses
- CWE-287
Description
Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.
Affected configurations
• bd alaris gs firmware (<= 2.3.6)
• bd alaris gh firmware (<= 2.3.6)
• bd alaris cc firmware (<= 2.3.6)
• bd alaris tiva firmware (<= 2.3.6)
Related
Weakness · CWE (1)
- CWE-287 Improper Authentication weakness
References
- http://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-plus-syringe-pumps-sold-and-in-use-outside-the-united-states Vendor Advisory
- http://www.securityfocus.com/bid/105147 Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01 Third Party Advisory, US Government Resource
- http://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-plus-syringe-pumps-sold-and-in-use-outside-the-united-states Vendor Advisory
- http://www.securityfocus.com/bid/105147 Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01 Third Party Advisory, US Government Resource